CoChat

First "Antisense" Drug Will Treat CMV Retinitis

Marwick, Charles · 1998 · JAMA

The DOI matches its Crossref record.

Abstract

A NEW CLASS of therapeutic agents known as "antisense" drugs is likely to become available to physicians within the next few months. These drugs operate at the molecular level, interrupting the process by which disease-causing proteins are produced.

Overview

Integrity signals

Registry

Crossref · 10.1001/jama.280.10.871-jmn0909-6-1

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 196

Metadata

Authors
Marwick, C.
Corresponding author
Marwick, Charles
Venue
JAMA
Published
1998-09-09
Volume
280
Issue
10
Pages
871
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2012222863
Cited by
167
References
0
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2022: 6 · 2021: 7 · 2020: 3 · 2019: 3 · 2018: 7 · 2017: 6 · 2016: 2 · 2015: 5 · 2014: 3 · 2013: 1 · 2012: 5
FWCI
8.39
Type
journal article
Language
en
Open access
closed
Locations
  • JAMA (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords
antisense therapeutics, cytomegalovirus retinitis, gene therapy, antiviral therapy, protein synthesis inhibition
MeSH terms
Antiviral Agents, Humans, Thionucleotides, AIDS-Related Opportunistic Infections, Cytomegalovirus Retinitis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: First "Antisense" Drug Will Treat CMV Retinitis. https://app.cochat.ai/papers/10.1001/jama.280.10.871-jmn0909-6-1
The paper
Marwick, C. (1998). First "Antisense" Drug Will Treat CMV Retinitis. JAMA. https://doi.org/10.1001/jama.280.10.871-jmn0909-6-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.